Published in J Immunol on June 15, 2003
Natural regulatory T cells and persistent viral infection. J Virol (2007) 1.62
Potential selection of LMP1 variants in nasopharyngeal carcinoma. J Virol (2004) 1.34
Role of regulatory T cells during virus infection. Immunol Rev (2013) 1.28
Clonal regulatory T cells specific for a red blood cell autoantigen in human autoimmune hemolytic anemia. Blood (2007) 1.05
The role of virus-induced regulatory T cells in immunopathology. Springer Semin Immunopathol (2006) 1.05
Human cytomegalovirus latency-associated proteins elicit immune-suppressive IL-10 producing CD4⁺ T cells. PLoS Pathog (2013) 0.99
The immunology of human cytomegalovirus latency: could latent infection be cleared by novel immunotherapeutic strategies? Cell Mol Immunol (2014) 0.95
Mechanism of T cell hyporesponsiveness to HBcAg is associated with regulatory T cells in chronic hepatitis B. World J Gastroenterol (2006) 0.90
Distinct roles of CD4+ T cell subpopulations in retroviral immunity: lessons from the Friend virus mouse model. Retrovirology (2011) 0.89
Epstein-Barr virus, rapamycin, and host immune responses. Curr Opin Organ Transplant (2008) 0.86
Lymphocyte deficiency limits Epstein-Barr virus latent membrane protein 1 induced chronic inflammation and carcinogenic pathology in vivo. Mol Cancer (2011) 0.85
PD-1/CTLA-4 Blockade Inhibits Epstein-Barr Virus-Induced Lymphoma Growth in a Cord Blood Humanized-Mouse Model. PLoS Pathog (2016) 0.84
Immune escape of γ-herpesviruses from adaptive immunity. Rev Med Virol (2014) 0.84
The impact of HLA class I and EBV latency-II antigen-specific CD8(+) T cells on the pathogenesis of EBV(+) Hodgkin lymphoma. Clin Exp Immunol (2015) 0.83
Epstein-Barr virus-specific CD8(+) T lymphocytes from diffuse large B cell lymphoma patients are functionally impaired. Clin Exp Immunol (2015) 0.81
Role of immune escape mechanisms in Hodgkin's lymphoma development and progression: a whole new world with therapeutic implications. Clin Dev Immunol (2012) 0.80
Regulatory T cells in arterivirus and coronavirus infections: do they protect against disease or enhance it? Viruses (2012) 0.79
Understanding the interplay between host immunity and Epstein-Barr virus in NPC patients. Emerg Microbes Infect (2015) 0.78
Therapeutic targeting of regulatory T cells enhances tumor-specific CD8+ T cell responses in Epstein-Barr virus associated nasopharyngeal carcinoma. Virology (2013) 0.78
Viral manipulation of the host immune response. Curr Opin Immunol (2015) 0.78
Enhancing cancer immunotherapy by intracellular delivery of cell-penetrating peptides and stimulation of pattern-recognition receptor signaling. Adv Immunol (2012) 0.78
Immune profiling and cancer post transplantation. World J Nephrol (2015) 0.77
Cytokine and immunoglobulin production by PWM-stimulated peripheral and tumor-infiltrating lymphocytes of undifferentiated nasopharyngeal carcinoma (NPC) patients. BMC Cancer (2004) 0.77
CD4 T cell responses in latent and chronic viral infections. Front Immunol (2013) 0.77
Induction of therapeutic antibodies by vaccination against external loops of tumor-associated viral latent membrane protein. J Virol (2009) 0.76
Complex effects of vitamin E and vitamin C supplementation on in vitro neonatal mononuclear cell responses to allergens. Nutrients (2013) 0.76
Epstein-Barr virus infection and nasopharyngeal carcinoma. Philos Trans R Soc Lond B Biol Sci (2017) 0.75
Regulatory T Cells in Endemic Burkitt Lymphoma Patients Are Associated with Poor Outcomes: A Prospective, Longitudinal Study. PLoS One (2016) 0.75
Therapeutic vaccine targeting Epstein-Barr virus latent protein, LMP1, suppresses LMP1-expressing tumor growth and metastasis in vivo. BMC Cancer (2017) 0.75
Regulatory CD4+CD25+ T Cells Dampen Inflammatory Disease in Murine Mycoplasma Pneumonia and Promote IL-17 and IFN-γ Responses. PLoS One (2016) 0.75
Identification of Four-Jointed Box 1 (FJX1)-Specific Peptides for Immunotherapy of Nasopharyngeal Carcinoma. PLoS One (2015) 0.75
The Immune Response to Epstein Barr Virus and Implications for Posttransplant Lymphoproliferative Disorder. Transplantation (2017) 0.75
Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma. Blood (2003) 2.47
Identification, immunomodulatory activity, and immunogenicity of the major helper T-cell epitope on the K blood group antigen. Blood (2012) 2.10
Suppressor of cytokine signaling (SOCS)1 is a key determinant of differential macrophage activation and function. J Leukoc Biol (2011) 1.82
The fine specificity and cytokine profile of T-helper cells responsive to the alpha3 chain of type IV collagen in Goodpasture's disease. J Am Soc Nephrol (2003) 1.70
Pulmonary and systemic effects of short-term inhalation exposure to ultrafine carbon black particles. Toxicol Appl Pharmacol (2004) 1.36
Local and systemic induction of CD4+CD25+ regulatory T-cell population by non-Hodgkin lymphoma. Blood (2008) 1.08
Clonal regulatory T cells specific for a red blood cell autoantigen in human autoimmune hemolytic anemia. Blood (2007) 1.05
Macrophages: promising targets for the treatment of atherosclerosis. Curr Vasc Pharmacol (2009) 1.01
Systematic review and meta-analysis of the sero-epidemiological association between Epstein Barr virus and multiple sclerosis. PLoS One (2013) 1.00
Rh autoantigen presentation to helper T cells in chronic lymphocytic leukemia by malignant B cells. Blood (2004) 1.00
Healthy individuals have Goodpasture autoantigen-reactive T cells. J Am Soc Nephrol (2008) 0.96
Peptides containing a dominant T-cell epitope from red cell band 3 have in vivo immunomodulatory properties in NZB mice with autoimmune hemolytic anemia. Blood (2003) 0.96
Interleukin-10-mediated regulatory T-cell responses to epitopes on a human red blood cell autoantigen. Blood (2002) 0.96
Evidence-based focused review of the treatment of idiopathic warm immune hemolytic anemia in adults. Blood (2011) 0.95
A critical role for suppressor of cytokine signalling 3 in promoting M1 macrophage activation and function in vitro and in vivo. Immunology (2014) 0.94
Mapping helper T-cell epitopes on platelet membrane glycoprotein IIIa in chronic autoimmune thrombocytopenic purpura. Blood (2007) 0.92
Effects of ultraviolet light on human serum 25-hydroxyvitamin D and systemic immune function. J Allergy Clin Immunol (2012) 0.91
Immune responses and tolerance to the RhD blood group protein in HLA-transgenic mice. Blood (2004) 0.90
The soluble isoform of CTLA-4 as a regulator of T-cell responses. Eur J Immunol (2013) 0.90
Systematic review and meta-analysis of the sero-epidemiological association between Epstein-Barr virus and systemic lupus erythematosus. Arthritis Res Ther (2014) 0.90
Cellular turnover of normal gastrointestinal epithelium assessed by changes in telomeric: total DNA signal ratios. Eur J Gastroenterol Hepatol (2003) 0.89
CD4(+) T-cell responses to Epstein-Barr virus (EBV) latent membrane protein 1 in infectious mononucleosis and EBV-associated non-Hodgkin lymphoma: Th1 in active disease but Tr1 in remission. Br J Haematol (2007) 0.88
A high rate of CLL phenotype lymphocytes in autoimmune hemolytic anemia and immune thrombocytopenic purpura. Haematologica (2008) 0.87
Expansion of Foxp3(+) T-cell populations by Candida albicans enhances both Th17-cell responses and fungal dissemination after intravenous challenge. Eur J Immunol (2014) 0.87
The activation status of human macrophages presenting antigen determines the efficiency of Th17 responses. Immunobiology (2015) 0.86
Refractory anemia with ring sideroblasts associated with marked thrombocytosis complicated by massive splenomegaly treated with lenalidomide resulting in resolution of splenomegaly but severe and prolonged pancytopenia. Case Rep Hematol (2013) 0.83
Deletion of the dominant autoantigen in NZB mice with autoimmune hemolytic anemia: effects on autoantibody and T-helper responses. Blood (2007) 0.83
Production of the effector cytokine interleukin-17, rather than interferon-γ, is more strongly associated with autoimmune hemolytic anemia. Haematologica (2012) 0.82
Controlling autoimmunity--Lessons from the study of red blood cells as model antigens. Immunol Lett (2006) 0.81
Characterization of the alloreactive helper T-cell response to the platelet membrane glycoprotein IIIa (integrin-beta3) in human platelet antigen-1a alloimmunized human platelet antigen-1b1b women. Transfusion (2005) 0.81
Characterization of the dominant autoreactive T-cell epitope in spontaneous autoimmune haemolytic anaemia of the NZB mouse. J Autoimmun (2002) 0.81
Different forms of helper tolerance to carcinoembryonic antigen: ignorance and regulation. Clin Cancer Res (2007) 0.80
The relationships between Epstein-Barr virus latent membrane protein 1 and regulatory T cells in Hodgkin's lymphoma. Exp Hematol (2007) 0.79
Targeting the alternatively spliced soluble isoform of CTLA-4: prospects for immunotherapy? Immunotherapy (2014) 0.78
Helper T cells point the way to specific immunotherapy for autoimmune disease. Cardiovasc Hematol Disord Drug Targets (2009) 0.78
Complex effects of vitamin E and vitamin C supplementation on in vitro neonatal mononuclear cell responses to allergens. Nutrients (2013) 0.76
Quantitative variation in plasma angiotensin-I converting enzyme activity shows allelic heterogeneity in the ABO blood group locus. Ann Hum Genet (2013) 0.76
Combination peptide immunotherapy suppresses antibody and helper T-cell responses to the RhD protein in HLA-transgenic mice. Haematologica (2014) 0.75
A case of apples and pears? Blood (2009) 0.75
Non-fatal haemophagocytic syndrome in an elderly patient. Age Ageing (2005) 0.75
Anti-endothelial antibodies interfere in apoptotic cell clearance and promote thrombosis in patients with antiphospholipid syndrome. J Immunol (2009) 0.75
Isolation, polarization, and expansion of CD4⁺ helper T cell lines and clones using magnetic beads. Methods Mol Biol (2014) 0.75
Increased red cell turnover in a line of CD22-deficient mice is caused by Gpi1c: a model for hereditary haemolytic anaemia. Eur J Immunol (2012) 0.75
Acute myeloid leukemia presenting in a mother and daughter pair with the identical acquired karyotypic abnormality consisting of inversion 3q21q26 and monosomy 7: a review of possible mechanisms. Cancer Genet (2012) 0.75